0001140361-15-022662.txt : 20150601 0001140361-15-022662.hdr.sgml : 20150601 20150601165939 ACCESSION NUMBER: 0001140361-15-022662 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150601 DATE AS OF CHANGE: 20150601 EFFECTIVENESS DATE: 20150601 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0000318306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830221517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-240904 FILM NUMBER: 15904166 BUSINESS ADDRESS: STREET 1: 2600 N STEMMONS FRWY STREET 2: STE 176 CITY: DALLAS STATE: TX ZIP: 75207 BUSINESS PHONE: 2149055100 MAIL ADDRESS: STREET 1: 2600 N STEMMONS FRWY STREET 2: STE 176 CITY: DALLAS STATE: TX ZIP: 75207 FORMER COMPANY: FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960209 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX CORP/WY DATE OF NAME CHANGE: 19831102 D 1 primary_doc.xml X0707 D LIVE 0000318306 PLASMATECH BIOPHARMACEUTICALS INC 4848 Lemmon Avenue Suite 517 DALLAS TX TEXAS 75219 214-905-5100 DELAWARE None ACCESS PHARMACEUTICALS INC CHEMEX PHARMACEUTICALS INC CHEMEX CORP/WY Corporation true Steven H. Rouhandeh c/o 4848 Lemmon Avenue. Suite 517 Dallas TX TEXAS 75219 Executive Officer Mr. Rouhandeh is the Executive Chairman of the Issuer. Stephen B. Thompson c/o 4848 Lemmon Avenue Suite 517 Dallas TX TEXAS 75219 Executive Officer Mr. Thompson is the Vice President - Finance, Treasurer and Secretary of the Issuer. Tim Miller c/o 4848 Lemmon Avenue Suite 517 Dallas TX TEXAS 75219 Executive Officer Director Dr. Miller is the President and Chief Executive Officer of the Issuer. Jeffrey H. Davis c/o 4848 Lemmon Avenue Suite 517 Dallas TX TEXAS 75219 Director Mark J. Ahn c/o 4848 Lemmon Avenue Suite 517 Dallas TX TEXAS 75219 Director Mark J. Alvino c/o 4848 Lemmon Avenue Suite 517 Dallas TX TEXAS 75219 Director Stephen B. Howell c/o 4848 Lemmon Avenue Suite 517 Dallas TX TEXAS 75219 Director Todd Wider c/o 4848 Lemmon Avenue Suite 517 Dallas TX TEXAS 75219 Director Pharmaceuticals Decline to Disclose 06b false 2015-05-15 false true true The offering is being made in connection with a merger. 0 22664509 13664509 9000000 Securities valued at $9,000,000 may be issued upon the realization of certain milestones. false 17 0 0 0 false PLASMATECH BIOPHARMACEUTICALS INC /s/ Stephen B. Thompson Stephen B. Thompson Vice President, Treasurer and Secretary of the Issuer 2015-06-01